Cytomegalovirus (CMV) Quantitative PCR
Some specimen types for this assay are reported as qualitative results; please see our Specimen Information section below for more information.
Cytomegalovirus (CMV) is an important pathogen in the transplant setting causing pneumonitis, colitis, hepatitis, CNS disease, neutropenia, and disseminated disease. Prior to the availability of rapid and sensitive DNA PCR, CMV was a leading cause of morbidity and mortality in the transplant population. Quantitative CMV DNA PCR can be used for early detection of CMV reactivation, primary infections, and monitoring response to treatment.
About Cytomegalovirus
Clinically significant Cytomegalovirus infection frequently develops in immunocompromised patient populations (e.g. hematopoietic stem cell transplantation, solid organ transplant and HIV). A frequent complication after transplantation, CMV infection may cause a series of direct and indirect effects that lead to increased incidence of graft rejection, opportunistic infections, and decreased allograft and patient survival.1,2 Symptomatic CMV disease in immunocompromised individuals can affect almost every organ of the body, resulting in fever, pneumonia, hepatitis, encephalitis, myelitis, colitis, uveitis, retinitis, and neuropathy.
ProcedureExtraction of CMV DNA from specimen followed by amplification and detection using real-time, quantitative PCR. An internal control is added to ensure the extraction was performed correctly and the PCR reaction was not inhibited. Eurofins Viracor's assay design includes multiple targets to account for viral mutations, which significantly reduces the chance of false negative results. This test has not been cleared or approved for diagnostic use by the U.S. Food and Drug Administration.
SpecificityThe primers and probes used in this assay are specific for known CMV strains based on similarity search algorithms. Additionally, no cross reactivity was detected when tested against adenoviruses, BKV, EBV, HSV-1, HSV-2, HHV-6 variant A, HHV-6 variant B, HHV-7, HHV-8, JCV, parvovirus B19, SV-40, and VZV.
Same day (within 8 - 12 hours from receipt of specimen), Monday through Saturday, with the exception of Tissue and Bone Marrow specimens. Tissue and Bone Marrow specimens are expected to report within 18-24 hours from receipt of specimen, Monday-Saturday.
Specimen Type | Test Code | CPT Code | NY Approved | Volume | Assay Range | Special Instructions |
---|---|---|---|---|---|---|
plasma | 5501 | 87497 | Yes | 2 mL (min. 0.8 mL) |
96 IU/mL to 1.88x108 IU/mL |
|
urine | 5502 | 87497 | Yes | 2 mL (min. 0.8 mL) |
475 IU/mL to 1.88x108 IU/mL |
|
CSF | 5503 | 87497 | Yes | 2 mL (min. 0.5 mL) |
142 IU/mL to 1.88x108 IU/mL |
|
bone marrow | 5504 | 87497 | Yes | 2 mL (min. 0.5 mL) |
1,039 IU/mL to 1.88x108 IU/mL |
|
Fresh Frozen Tissue [Quant] | 5505 | 87497 | Yes | 5 mg fresh tissue (approximately ½ of a pencil eraser size) |
37 IU/mg to 1.88x107 IU/mg |
|
Fresh Frozen Tissue [Qual] | 5506 | 87496 | Yes | 5 mg fresh tissue (approximately ½ of a pencil eraser size) | Detected/Not Detected |
|
amniotic fluid | 5507 | 87497 | Yes | 2 mL (min. 0.5 mL) |
104 IU/mL to 1.88x108 IU/mL |
|
fecal | 5508 | 87496 | Yes | Size of pea, or 2 mL liquid stool | Detected/Not Detected |
|
BAL | 5509 | 87497 | Yes | 2 mL (min. 0.5 mL) |
79 IU/mL to 1.88x108 IU/mL |
|
serum | 5510 | 87497 | Yes | 2 mL (min. 0.8 mL) |
96 IU/mL to 1.88x108 IU/mL |
|
pleural fluid | 5511 | 87497 | Yes | 2 mL (min. 0.5 mL) |
104 IU/mL to 1.88x108 IU/mL |
|
pericardial fluid | 5512 | 87497 | Yes | 2 mL (min. 0.5 mL) |
104 IU/mL to 1.88x108 IU/mL |
|
vitreous fluid | 5514 | 87497 | Yes | 0.25 mL (min. 0.05 mL) |
1,423 IU/mL to 1.88x108 IU/mL |
|
trach asp | 5519 | 87497 | Yes | 2 mL (min. 0.5 mL) |
79 IU/mL to 1.88x108 IU/mL |
|
bronch wash | 5526 | 87497 | Yes | 2 mL (min. 0.5 mL) |
79 IU/mL to 1.88x108 IU/mL |
|
eye swab | 5527 | 87496 | Yes | 2 mL |
Detected/Not Detected |
|
aqueous fluid | 5545 | 87497 | Yes | 0.25 mL (min. 0.05 mL) |
1,423 IU/mL to 1.88x108 IU/mL |
|
trach wash | 5548 | 87497 | Yes | 2 mL (min. 0.5 mL) |
79 IU/mL to 1.88x108 IU/mL |
|
saliva | 5571 | 87496 | Yes | 1 mL |
Detected/Not Detected |
|
Ship Monday through Friday. Friday shipments must be labeled for Saturday delivery. All specimens must be labeled with patient's name and collection date. A Eurofins Viracor test requisition form must accompany each specimen. Multiple tests can be run on one specimen. Ship specimens FedEx Priority Overnight® to: Eurofins Viracor, 18000 W 99th St. Ste, #10, Lenexa, KS 66219
Causes for RejectionWhole blood frozen, grossly hemolyzed plasma/serum specimens, specimens beyond their acceptable length of time from collection as listed in the specimen handling, specimens received in trap containers, or specimen types other than those listed.
Specimens are approved for testing in New York only when indicated in the Specimen Information field above.
The CPT codes provided are based on Eurofins Viracor's interpretation of the American Medical Association's Current Procedural Terminology (CPT) codes and are provided for informational purposes only. CPT coding is the sole responsibility of the billing party. Questions regarding coding should be addressed to your local Medicare carrier. Eurofins Viracor assumes no responsibility for billing errors due to reliance on the CPT codes illustrated in this material.
References1 Kotton CN, Kumar D, Caliendo AM, et al. International consensus guidelines on the management of cytomegalovirus in solid organ transplantation. Transplantation. Apr 15 2010;89(7):779-95.
2 Boeckh M, Ljungman P. How we treat cytomegalovirus in hematopoietic cell transplant recipients. Blood. 2009;113(23):5711-9.